Pancreatic Ductal Adenocarcinoma Withdrawn Phase 1 / 2 Trials for Fluorouracil (DB00544)

IndicationStatusPhase
DBCOND0034446 (Pancreatic Ductal Adenocarcinoma)Withdrawn1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02575508Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic CancerTreatment